发明名称 DNA encoding SNORF36 receptors
摘要 This invention provides isolated nucleic acids encoding mammalian SNORF36 receptors, purified mammalian SNORF36 receptors, vectors comprising nucleic acid encoding mammalian SNORF36 receptors, cells comprising such vectors, antibodies directed to mammalian SNORF36 receptors, nucleic acid probes useful for detecting nucleic acid encoding mammalian SNORF36 receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding mammalian SNORF36 receptors, transgenic, nonhuman animals which express DNA encoding normal or mutant mammalian SNORF36 receptors, methods of isolating mammalian SNORF36 receptors, methods of treating an abnormality that is linked to the activity of the mammalian SNORF36 receptors, as well as methods of determining binding of compounds to mammalian SNORF36 receptors, methods of identifying agonists and antagonists of SNORF36 receptors, and agonists and antagonists so identified.
申请公布号 US2003073167(A1) 申请公布日期 2003.04.17
申请号 US20020146835 申请日期 2002.05.16
申请人 SYNAPTIC PHARMACEUTICAL CORPORATION 发明人 BOROWSKY BETH E.;OGOZALEK KRISTINE L.;LAKHLANI PARUL P.;ADHAM NIKA
分类号 G01N33/50;A61K31/7088;A61K38/00;A61K45/00;A61K48/00;A61P1/00;A61P1/08;A61P3/00;A61P3/04;A61P3/10;A61P3/12;A61P5/00;A61P5/38;A61P7/02;A61P7/04;A61P9/00;A61P9/02;A61P9/04;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P13/02;A61P13/08;A61P13/12;A61P15/08;A61P15/10;A61P17/00;A61P19/02;A61P19/08;A61P19/10;A61P25/00;A61P25/02;A61P25/04;A61P25/06;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P27/16;A61P29/00;A61P29/02;A61P31/04;A61P31/10;A61P31/12;A61P31/18;A61P33/02;A61P35/00;A61P37/02;A61P37/04;A61P37/08;A61P43/00;C07K14/705;C07K16/28;C12N1/21;C12N5/10;C12N15/09;C12P21/02;C12P21/08;C12Q1/02;C12Q1/68;G01N33/15;G01N33/53;G01N33/566;G01N33/567;(IPC1-7):C07K14/705;C12N5/06;C07H21/04 主分类号 G01N33/50
代理机构 代理人
主权项
地址